Background. The current treatment regimes for patients with nephrotic syndrome due to
idiopathic membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS) …

Background: Retrospective and anecdotal data suggest that mycophenolate mofetil (MMF)
might be effective when given as rescue therapy for membranous nephropathy (MN) …

BACKGROUND: Cyclophosphamide can decrease proteinuria and improve renal function in
patients with idiopathic membranous nephropathy, but has a high risk of side effects. We …

BACKGROUND: Treatment of patients with membranous glomerulonephritis (MGN) is
controversial because of the lack of clear benefit of the immunosuppressive regimens on …

Idiopathic membranous nephropathy (IMN) remains one of the most common causes of the
nephrotic syndrome (NS) in adults. Although the natural history is extremely variable …

Background. Treatment of adults with idiopathic membranoproliferative glomerulonephritis
(IMPGN) is often unrewarding with∼ 60% of patients progressing to end-stage renal failure …

Background Appropriate immunosuppressive therapy for patients with idiopathic
membranous nephropathy (MN) remains controversial. The effect of mycophenolate mofetil …

Mycophenolate mofetil treatment for primary glomerular diseases. Background Treatment of
primary glomerular diseases may be unsuccessful or have potential toxicities. Therefore, we …

Background. Membranous nephropathy is a common cause of nephrotic syndrome (NS) in
adults. Its treatment is still under debate. Methods. We report our experience in a pilot study …

Sir, Initial reports of treatment of patients with various glomerular diseases with
mycophenolate mofetil (MMF) showed that partial or complete remissions of nephrotic …